English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Dec 9, 2025
Prehabilitation reduces post-surgery disability in frail older adults if fully completed
Patient Daily
| Dec 9, 2025
MIT develops noninvasive blood-glucose monitor aiming to replace finger-prick tests
Patient Daily
| Dec 9, 2025
Turnover continues among top FDA officials amid growing regulatory uncertainty
Patient Daily
| Dec 9, 2025
Lilly and Novo Nordisk drug pricing changes open market opportunities for rivals
Patient Daily
| Dec 9, 2025
Penn Medicine appoints new leaders aiming to reshape undergraduate and graduate medical education
Patient Daily
| Dec 9, 2025
Prasad memo prompts debate as FDA sees leadership changes and new drug data emerges
Patient Daily
| Dec 9, 2025
Bristol Myers Squibb postpones Alzheimer’s psychosis drug trial results after site irregularities
Patient Daily
| Dec 9, 2025
UTHealth Houston researchers secure nearly $10 million for diverse state-backed cancer initiatives
Trending
+
Regulatory
B. D. Benavides
| Mar 18, 2026
Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'
+
Pharmaceuticals
Patient Daily
| Mar 22, 2026
BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+
Regulatory
Patient Daily
| Mar 20, 2026
Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+
Pharmaceuticals
Patient Daily
| Mar 22, 2026
FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
« First
«
…
96
97
98
99
100
101
102
…
»
Last »